Vor Biopharma Inc. - stock earnings
VOR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -26.3 million USD | ? USD |
| 2023Q3 | -33.2 million USD | ? USD |
| 2023Q2 | -30.0 million USD | ? USD |
| 2023Q1 | -26.4 million USD | ? USD |
| 2022Q4 | -22.9 million USD | ? USD |
| 2022Q3 | -23.5 million USD | ? USD |
| 2022Q2 | -21.5 million USD | ? USD |
| 2022Q1 | -22.7 million USD | ? USD |
| 2021Q4 | -18.3 million USD | ? USD |
| 2021Q3 | -18.6 million USD | ? USD |
| 2021Q2 | -18.4 million USD | ? USD |
| 2021Q1 | -13.7 million USD | ? USD |
| 2020Q4 | -15.7 million USD | ? USD |
| 2020Q3 | -11.8 million USD | ? USD |
| 2020Q2 | -8.0 million USD | ? USD |
| 2020Q1 | -7.8 million USD | ? USD |
| 2019Q4 | -3.9 million USD | ? USD |
VOR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -117.9 million USD | ? USD |
| 2022 | -90.8 million USD | ? USD |
| 2021 | -68.8 million USD | ? USD |
| 2020 | -43.3 million USD | ? USD |
| 2019 | -11.4 million USD | ? USD |
| 2018 | -4.2 million USD | ? USD |
VOR
Price: $1.69
52 week price:
Earnings Per Share: -1.75 USD
P/E Ratio: -1.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 63919
Market Capitalization: 129.6 million